The imaging platform built for multicentre clinical trials.
Dixit is an imaging CRO powered by WIDEN, a proprietary imaging core lab platform that standardises, reviews, and archives imaging data for complex clinical studies.
We help sponsors reduce variability, improve endpoint reliability and accelerate regulatory readiness through controlled, traceable imaging workflows.
One platform.
One operational model.
Imaging Data Governance
We centralise imaging transfer, quality control, central review, traceability and regulatory archiving within one secure and standardised environment.
Multicentre Standardisation
We harmonise imaging workflows across global sites to improve quantitative consistency and comparability between centres.
Scientific & Regulatory Oversight
Our imaging and clinical experts support complex studies with methodological rigour and inspection-ready processes.
The imaging core lab platform behind every workflow.
WIDEN is a proprietary web-based imaging platform developed to support multicentre clinical trials through controlled workflows, data traceability and regulatory-ready governance.
Designed for complex imaging studies, WIDEN integrates transfer, quality control, reviewer workflows, audit trail and secure archiving in one unified environment.
- Secure imaging transfer. Centralised and protected DICOM upload and data exchange across global clinical sites.
- Workflow traceability. Complete audit trail and monitoring across every phase of the imaging lifecycle.
- Quality control oversight. Protocol compliance checks and proactive identification of acquisition deviations.
- Central review environment. Structured reviewer workflows designed to improve consistency and endpoint reliability.
- Long-term archiving. Long-term compliant archiving with traceability and inspection support.
- Multicentre coordination. Operational visibility across sites, reviewers and imaging activities.
Illustrative interface — sample data, not client results.
Operational imaging solutions for complex clinical trials.
We govern imaging workflows from acquisition to final review through controlled processes designed to ensure data consistency, traceability and regulatory readiness.
Advanced scientific support available for imaging-intensive studies.
While WIDEN and Dixit provide structured imaging governance, selected clinical
trial programmes may benefit from additional scientific expertise in quantitative
imaging, radiopharmaceutical development, dosimetry and radiomics.
These capabilities are integrated within our operational workflows when
required by study design.
Quantitative imaging
Standardised imaging biomarkers and quantitative methodologies integrated into clinical workflows.
Dosimetry services
Patient-specific dosimetric analysis supporting radiopharmaceutical and theranostic studies.
Radiopharma support
Scientific support for PET/SPECT harmonisation, molecular imaging workflows and radiopharmaceutical development.
On-demand radiomics
Extraction and harmonisation of quantitative imaging features for exploratory and translational endpoints.
Built for scientific rigour.
Designed for operational control.
Whether you’re a sponsor or CRO running a registrational programme, or an academic centre running an investigator-initiated study, WIDEN handles the operational weight so your team doesn’t have to.
Reliable endpoints.
Controlled imaging workflow designed to reduce variability.
Regulatory confidence.
Inspection-ready governance and complete traceability.
Scalable multicentre execution.
Consistent imaging operations across worldwide-distributed clinical trials.
Our methodology is published, not asserted.
Peer-reviewed papers describe the platform, the standardisation methods and the trials that ran on them — and the investigators who rely on it are named.
In investigator-initiated multicentre trials such as TheraP and UpFrontPSMA, imaging was central to the study design – it was used directly for patient selection, confirmation of eligibility and treatment decisions, not simply as an exploratory endpoint. WIDEN gave us a single, reliable workflow for transferring, quality-checking and reviewing PSMA and FDG PET/CT studies from all participating sites. It also made blinded independent reads, communication between the imaging core laboratory and investigators, and documentation of consensus straightforward and well-organised. Sites and reviewers found the system intuitive and easy to use, yet it remained flexible enough to adapt to the specific requirements of molecular imaging and theranostic trials. In practice, WIDEN allowed us to run the imaging component of these trials consistently and efficiently across sites, and to complete image review and reporting seamlessly within the trial workflow. It was a valuable part of delivering these studies to a high standard.
The Dixit network — sites running on our infrastructure today.
Managing imaging across multiple countries and clinical sites requires more than coordination — it requires methodological control.
Dixit supports multicentre international studies through standardised workflows, harmonised acquisition protocols and centralised imaging governance powered by WIDEN.
Our approach ensures that imaging data remain consistent, traceable and regulatory-ready across every participating site.
What the network has carried so far.
Dixit and WIDEN have powered imaging operations for trials of every shape — from single-site early-phase studies to multi-country Phase III networks.
Let’s discuss your imaging strategy.
From site qualification to imaging governance, we help sponsors reduce variability, strengthen endpoints and improve regulatory readiness in complex clinical studies.